Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 22 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

45%

10 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 4
5(35.7%)
Phase 3
5(35.7%)
N/A
2(14.3%)
Phase 2
1(7.1%)
Phase 1
1(7.1%)
14Total
Phase 4(5)
Phase 3(5)
N/A(2)
Phase 2(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials
NCT04528511Recruiting

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction

Role: collaborator

NCT07345624Phase 4Not Yet Recruiting

Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B

Role: collaborator

NCT07345611Phase 4Not Yet Recruiting

Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B

Role: collaborator

NCT03649503Recruiting

The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China

Role: collaborator

NCT02737189Not ApplicableCompleted

Basilar Artery Occlusion Chinese Endovascular Trial

Role: collaborator

NCT06349655Completed

The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19

Role: collaborator

NCT05694273Not Yet Recruiting

Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation

Role: collaborator

NCT04681651Phase 2Completed

Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

Role: collaborator

NCT03909438Unknown

Investigation and Study on the Status of Endovascular Therapy in Acute Ischemic Stroke Ischemic Stroke

Role: collaborator

NCT02025036Phase 3Unknown

Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer

Role: collaborator

NCT05282563Not ApplicableUnknown

Clinical Study on the Safety of Double and a Half Layered Esophagojejunal Anastomosis in Curative Gastrectomy

Role: collaborator

NCT04850950Phase 4Unknown

Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B

Role: collaborator

NCT02473406Phase 4Completed

Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis

Role: collaborator

NCT04398823Phase 4Unknown

A Multicenter Prospective Clinical Study of Endoscopic Foam Sclerotherapy for Internal Hemorrhoids

Role: collaborator

NCT04020536Recruiting

Real World Study of Classic Infectious Disease

Role: collaborator

NCT03913312Phase 1Unknown

Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML

Role: collaborator

NCT03950518Phase 3Unknown

Novel Treatment of Advanced Hepatocellular Carcinoma

Role: collaborator

NCT03940378Phase 3Unknown

Treatment of Advanced Intrahepatic Cholangiocarcinoma

Role: collaborator

NCT03274427Phase 3Unknown

Treatment of Intermediate-stage Hepatocellular Carcinoma

Role: collaborator

NCT03278444Phase 3Unknown

Treatment of Advanced Hepatocellular Carcinoma

Role: collaborator